Australian Clinical Labs Limited (ACL.AX)
AUD 2.97
(-2.3%)
AUD 2.97
(-2.3%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 55.06 Million AUD | -16.18% |
| 2023 | 215.23 Million AUD | 28.41% |
| 2022 | 167.61 Million AUD | -25.19% |
| 2021 | 224.05 Million AUD | 272.99% |
| 2020 | 60.07 Million AUD | 7.27% |
| 2019 | 55.99 Million AUD | 7.25% |
| 2018 | 52.21 Million AUD | 8.18% |
| 2017 | 48.26 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 225.26 Million AUD | 19.81% |
| 2024 Q4 | 55.06 Million AUD | 0.0% |
| 2024 Q2 | 78.7 Million AUD | 0.0% |
| 2024 FY | 55.06 Million AUD | -74.42% |
| 2024 Q3 | 55.06 Million AUD | -30.04% |
| 2023 Q1 | 225.78 Million AUD | 34.71% |
| 2023 FY | 215.23 Million AUD | 28.41% |
| 2023 Q2 | 65.89 Million AUD | -70.81% |
| 2023 Q4 | 215.23 Million AUD | 0.0% |
| 2023 Q3 | 215.23 Million AUD | 226.61% |
| 2022 Q2 | 44.55 Million AUD | -77.53% |
| 2022 Q1 | 198.28 Million AUD | 99.26% |
| 2022 FY | 167.61 Million AUD | -25.19% |
| 2022 Q4 | 167.61 Million AUD | 0.0% |
| 2022 Q3 | 167.61 Million AUD | 276.15% |
| 2021 FY | 224.05 Million AUD | 272.99% |
| 2021 Q4 | 99.51 Million AUD | -57.45% |
| 2021 Q3 | 233.85 Million AUD | 22.18% |
| 2021 Q2 | 191.4 Million AUD | -3.91% |
| 2021 Q1 | 199.2 Million AUD | 231.61% |
| 2020 Q4 | 60.07 Million AUD | -61.92% |
| 2020 Q3 | 157.76 Million AUD | 0.0% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 FY | 60.07 Million AUD | 7.27% |
| 2019 FY | 55.99 Million AUD | 7.25% |
| 2018 FY | 52.21 Million AUD | 8.18% |
| 2017 FY | 48.26 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| BCAL Diagnostics Limited | 400.22 Thousand AUD | -13658.398% |
| Genetic Signatures Limited | - AUD | -Infinity% |
| Genetic Technologies Limited | - AUD | -Infinity% |
| Healius Limited | 420.8 Million AUD | 86.914% |
| Imagion Biosystems Limited | 750 Thousand AUD | -7241.867% |
| Integral Diagnostics Limited | 219.75 Million AUD | 74.943% |
| INOVIQ Ltd | - AUD | -Infinity% |
| Microba Life Sciences Limited | - AUD | -Infinity% |
| Monash IVF Group Limited | 59.56 Million AUD | 7.556% |
| Rhythm Biosciences Limited | - AUD | -Infinity% |
| Sonic Healthcare Limited | 2.69 Billion AUD | 97.953% |